Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers
Hollmén, Maija, Maksimow, Mikael, Rannikko, Jenna H, Karvonen, Matti K, Vainio, Marita, Jalkanen, Sirpa, Jalkanen, Markku, Mandelin, Jami
Published in Molecular cancer therapeutics (05.07.2022)
Published in Molecular cancer therapeutics (05.07.2022)
Get full text
Journal Article